Case Management Working Group (CMWG)
The RBM CMWG is a dynamic and systematic coordination, convening and facilitating mechanism at global level that aims to: minimize wasteful duplication and maximize synergies, encourage harmonization and pooling of efforts for faster uptake and scale up of malaria case management strategies.
The Working Group aims to achieve consensus on complex strategic issues concerning scaling up implementation of policies for malaria case management, and on synthesizing and disseminating evidence-based best practice. This will be done without duplicating the essential responsibility of WHO expert committees and consultations, which is to advise on norms and standards for products and services and their appropriate use.
One of the four essential elements of the RBM strategy is access to prompt and effective treatment for malarial disease. Increasing drug resistance, warranting the use of new treatments, combined with weak health systems has made it difficult to ensure that prompt, effective treatment is available and affordable to those who need it. Scaling up access to effective treatment of malaria cases will be contingent on well coordinated, multi-disciplinary action towards defined objectives, systems, services and products.
In September and October 2002, RBM partners met in Geneva to discuss access to malaria treatment issues. This meeting endorsed the formation of the Case Management Working Group (CMWG). In accordance with the Operating Framework of the Roll Back Malaria (RBM) Partnership, the malaria Case Management Working Group (CMWG) has been re-established by the Board in July 2009, following a period of relative inactivity.
Functions of the Working Group
The activities of the CMWG will include, but not be limited to, the following:
Convene: the CMWG brings together a group of partners who work on use of diagnostic methods, improving drug provision, ensuring access to affordable quality drugs and quality treatment advice in both the public and private sectors, improving provider and patient use of malaria drugs, mitigating the risks of antimalarial drug resistance, and measuring the impact of implementation scale up on morbidity. The CMWG can also help identify necessary expertise and experts to bring in on a temporary, ad hoc basis to assist with addressing issues outside of the expertise of the CMWG itself.
Co-ordinate: by bringing the Partners together, gives a forum for the Partners to co-ordinate their:
- Developing and maintaining consensus across partners and institutions around strategies for improved effectiveness of key components of case management.
- Identifying critical strategic questions related to malaria case management. Organizing task forces with the partnership secretariat to address these, drawing on a wider range of expertise than is directly represented in the CMWG.
- Examining how effective case management, in accordance with country policies and WHO recommendations, can be taken to scale, sustained and adapted for elimination in endemic countries most efficiently.
- Liaising and coordinating with other relevant Working Groups, institutions, programmes, initiatives, networks and activities, towards RBM objectives to ensure that work reflects changing needs.
- Collaborating with other RBM Working Groups whose work is relevant to, or overlaps with case management to deal effectively with cross cutting issues pertinent to case management.
- Assisting the RBM partnership to develop an appropriate research agenda and promote research.
Facilitate Communication: by bringing Partners together, the CMWG is a forum for communication and mutual learning. Key functions:
- Accelerating flow of information to countries and others in the RBM partnership on developments within other programmes, institutions and initiatives that may have relevance for RBM and case management, including progress in drug development.
- Advising the Board on allocation of resources and capacity building needs for achieving the objective of scaling up effective case management.
- Advocating for increased attention to and resources for effective malaria case management.
- Other activities as requested by the RBM Secretariat or Board within the scope of its expertise and functions.
For further information please refer to the CMWG Revised Terms of Reference adopted in January 2014 following the 25th RBM Partnership Board meeting.
The CMWG has established 4 work streams for further development within the context of the RBM Partnership Workplan.
Chair : Lawrence Barat (USAID/PMI)
Next meeting : TBD
Work Stream products
- Diagnostic Testing in the Retail Private Sector: Lessons Learned (Seventh CMWG meeting)
- Diagnosis Workstream Progress Update (Fifth CMWG meeting)
- Implementing Universal Malaria Diagnosis in National Programmes [PDF 457K]
- MalariaDx Guide for implementation [Excel 35K]
Other Useful Documents
Strategies to improve access to treatment at all levels of health care
Work Streem products coming soon
Drug Resistance Management
Work Streem products
- Drug Resistance Management Work Stream Progress (Fifth CMWG meeting)
Leaders : Prof Alex Dodoo, WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, University of Ghana Medical School, Ghana, Prof Paul Lalvani, Empower School of Health, India, Dr Shanthi Pal, WHO
RBM Secretariat Focal point : Dr Jan Van Erps, Tel.: +41 22 791 5867
Next meeting : TBD
The last few years have seen an increased and concerted effort by several global players including the World Health Organisation, the Roll Back Malaria Partnership and the Bill & Melinda Gates Foundation to provide the tools, interventions and resources needed to control malaria with a view to elimination and eradication as soon as feasible. One of the cornerstones of these campaigns is increased availability of good quality affordable artemisinin-based combination treatment (ACT) for the management of uncomplicated malaria. The aim is to ensure that ACTs are available to everyone who needs them in all settings. Such widespread deployment of ACTs needs to be accompanied by robust pharmacovigilance (PV) systems to assure patient safety.
The efforts of WHO’s Collaboration Centre for International Drug Monitoring, the Uppsala Monitoring Centre (UMC) need to be complemented by those of other partners in order to raise the needed funds and provide the expected advocacy and technical assistance to ensure optimum development and deployment of PV systems in countries where ACTs are being rolled out on a large scale.
Until December 2012 Pharmacovigilance Workstream was a part of RBM Procurement and Supply Chain Management Working Group (PSMWG). For further information, please refer to the Pharmacovigilance Work Stream Terms of Reference.
- Malaria Pharmacovigilance Toolkit, 2012.
A collection of resources and information needed for the practice of pharmacovigilance. The main aim of its development is to ensure that PV practitioners in low- and middle-income countries get access to information on the processes and activities involved in PV from a trusted source. The Malaria Pharmacovigilance Toolkit is one of the three disease specific toolkits included on the website in addition to the HIV and TB PV Toolkits.
- Pharmaceutical Systems Strengthening and Pharmacovigilance, Global Fund Round 11 Information Note, 2011
- Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring, 2011.
- Mapping of malaria focused pharmacovigilance capacities and activities in countries served by the AMFm, 2011
- Pharmacovigilance guidance for countries participating in AMFm Phase 1, 2009
- Steps for Accessing Funding from Global Fund for Pharmacovigilance for Ongoing Grants, 2008
List of participants
|26-27.05.2004||What’s worked and where do we go from here? Meeting Report
Interventions to Improve the Role of Medicine Sellers in Malaria Case Management for Children in Africa
|5-6.09.2003||Minutes of the meeting|
|21-22.03.2003||Minutes of the meeting [MS Word 283K]
DRAFT Strategic Framework for Scaling up Effective Malaria Case Management — updated 1 March 2004 [PDF 148K]